aripiprazole 10 MG Oral Tablet [Abilify]
aripiprazole
RxCUI: 352307
What the CMS Formulary Data Shows for aripiprazole 10 MG Oral Tablet [Abilify]
Per the CMS 2026 Part D formulary file, aripiprazole 10 MG Oral Tablet [Abilify] (RxNorm concept RXCUI 352307, generic name aripiprazole) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to aripiprazole 10 MG Oral Tablet [Abilify] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 613,179 Part D beneficiaries filled aripiprazole 10 MG Oral Tablet [Abilify] in 2023, with total plan-and-beneficiary spending of $372,728,723 and an average per-beneficiary annual cost of $607.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry aripiprazole 10 MG Oral Tablet [Abilify] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 613,179
- Total spending
- $372,728,723
- Avg per beneficiary
- $607.86
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering aripiprazole 10 MG Oral Tablet [Abilify]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $34.50 | NY |
Frequently Asked Questions
Is aripiprazole 10 MG Oral Tablet [Abilify] covered by Medicare Part D?
Yes, aripiprazole 10 MG Oral Tablet [Abilify] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is aripiprazole 10 MG Oral Tablet [Abilify] on Medicare Part D plans?
aripiprazole 10 MG Oral Tablet [Abilify] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does aripiprazole 10 MG Oral Tablet [Abilify] require prior authorization?
100% of Part D formularies require prior authorization for aripiprazole 10 MG Oral Tablet [Abilify]. Step therapy: 0%. Quantity limits: 100%.
How much does Medicare spend on aripiprazole 10 MG Oral Tablet [Abilify]?
In 2023, total Medicare Part D spending on aripiprazole 10 MG Oral Tablet [Abilify] was $372,728,723, covering 613,179 beneficiaries. The average spend per beneficiary was $607.86.
Read our methodology - how this data is sourced, computed, and verified.